These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21355960)

  • 21. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.
    Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
    Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
    Buergy D; Weber T; Maurer GD; Mudduluru G; Medved F; Leupold JH; Brauckhoff M; Post S; Dralle H; Allgayer H
    Int J Cancer; 2009 Aug; 125(4):894-901. PubMed ID: 19480010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular signatures of thyroid follicular neoplasia.
    Borup R; Rossing M; Henao R; Yamamoto Y; Krogdahl A; Godballe C; Winther O; Kiss K; Christensen L; Høgdall E; Bennedbaek F; Nielsen FC
    Endocr Relat Cancer; 2010 Sep; 17(3):691-708. PubMed ID: 20668010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression of GADD153 in follicular tumors of thyroid and comparison with CK19, Galectin-3 and HBME-1].
    Tang QS; Teng XD; Ding W; Zhou J; Yao HT; Ying LX; Xu LM
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):745-8. PubMed ID: 22336157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
    Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
    Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular markers for discrimination of benign and malignant follicular thyroid tumors.
    Fryknäs M; Wickenberg-Bolin U; Göransson H; Gustafsson MG; Foukakis T; Lee JJ; Landegren U; Höög A; Larsson C; Grimelius L; Wallin G; Pettersson U; Isaksson A
    Tumour Biol; 2006; 27(4):211-20. PubMed ID: 16675914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promising molecular techniques for discriminating among follicular thyroid neoplasms.
    Carroll NM; Carty SE
    Surg Oncol; 2006 Aug; 15(2):59-64. PubMed ID: 16949814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Follicular thyroid lesions, elements that affect both diagnosis and prognosis.
    Zeiger MA; Dackiw AP
    J Surg Oncol; 2005 Mar; 89(3):108-13. PubMed ID: 15719377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of immunohistochemical markers in diagnosis of follicular cell derived thyroid lesions.
    Alshenawy HA
    Pathol Oncol Res; 2014 Oct; 20(4):819-28. PubMed ID: 24659044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma.
    Rossing M; Borup R; Henao R; Winther O; Vikesaa J; Niazi O; Godballe C; Krogdahl A; Glud M; Hjort-Sørensen C; Kiss K; Bennedbæk FN; Nielsen FC
    J Mol Endocrinol; 2012 Feb; 48(1):11-23. PubMed ID: 22049245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Problems in the diagnosis of thyroid papillary and follicular carcinoma].
    Xue WC; Hui YZ
    Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):220-3. PubMed ID: 17706110
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
    Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM
    Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Micro-RNAs in thyroid neoplasms: molecular, diagnostic and therapeutic implications.
    Menon MP; Khan A
    J Clin Pathol; 2009 Nov; 62(11):978-85. PubMed ID: 19625289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of estrogen receptor Beta expression in follicular thyroid carcinoma predicts poor outcome.
    Heikkilä A; Hagström J; Mäenpää H; Louhimo J; Siironen P; Heiskanen I; Haglund C; Arola J
    Thyroid; 2013 Apr; 23(4):456-65. PubMed ID: 23106428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA microarray and miRNA analyses reinforce the classification of follicular thyroid tumors.
    Jacques C; Guillotin D; Fontaine JF; Franc B; Mirebeau-Prunier D; Fleury A; Malthiery Y; Savagner F
    J Clin Endocrinol Metab; 2013 May; 98(5):E981-9. PubMed ID: 23569218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of matrix metalloproteinases in benign and malignant follicular thyroid lesions.
    Cho Mar K; Eimoto T; Tateyama H; Arai Y; Fujiyoshi Y; Hamaguchi M
    Histopathology; 2006 Feb; 48(3):286-94. PubMed ID: 16430475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular and capsular pseudoinvasion in thyroid neoplasms.
    Chebib I; Opher E; Richardson ME
    Int J Surg Pathol; 2009 Dec; 17(6):449-51. PubMed ID: 19666948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Problems in pathologic diagnosis of thyroid follicular cell carcinoma].
    Li Y; Huo Z; Chen J
    Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):348-52. PubMed ID: 25030874
    [No Abstract]   [Full Text] [Related]  

  • 39. Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours.
    Wojtas B; Pfeifer A; Oczko-Wojciechowska M; Krajewska J; Czarniecka A; Kukulska A; Eszlinger M; Musholt T; Stokowy T; Swierniak M; Stobiecka E; Chmielik E; Rusinek D; Tyszkiewicz T; Halczok M; Hauptmann S; Lange D; Jarzab M; Paschke R; Jarzab B
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28574441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The advances of molecular pathology of follicular thyroid carcinoma].
    Zhan Y; Cui QC
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):268-70. PubMed ID: 15256127
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.